GW Phar­ma shares surge on pos­i­tive PhI­II fol­lowup; Il­lu­mi­na leads $18M round for Stil­la's DNA tech

→ GW Phar­ma $GW­PH al­ready won their big FDA ap­proval to sell Epid­i­olex for rare seizure cas­es, set­ting the ground­break­ing cannabi­noid drug on track to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.